Search Results - Laurent Mathiot
- Showing 1 - 5 results of 5
-
1
HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature by Laurent Mathiot, Guillaume Herbreteau, Siméon Robin, Charlotte Fenat, Jaafar Bennouna, Christophe Blanquart, Marc Denis, Elvire Pons-Tostivint
Published in Current Oncology (2022-05-01)Get full text
Article -
2
Monitoring concentration and lipid signature of plasma extracellular vesicles from HR+ metastatic breast cancer patients under CDK4/6 inhibitors treatment by Mathilde Richard, Rosalie Moreau, Mikaël Croyal, Laurent Mathiot, Jean‐Sébastien Frénel, Mario Campone, Aurélien Dupont, Julie Gavard, Gwennan André‐Grégoire, Laëtitia Guével
Published in Journal of Extracellular Biology (2024-12-01)Get full text
Article -
3
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors by Stephane Champiat, Francois-Xavier Danlos, Aurélien Marabelle, Yohann Loriot, Julia Delahousse, Kaïssa Ouali, Santiago Ponce, Laurent Mathiot, David Combarel, Justin Cagnat, Sophie Broutin
Published in Journal for ImmunoTherapy of Cancer (2024-05-01)Get full text
Article -
4
Real-world analysis of HER2-ultralow in HR+/HER2– metastatic breast cancer: prevalence and first-line chemotherapy outcomes by Laurent Mathiot, Olivier Kerdraon, Florent Le Borgne, Véronique Verriele, Anne Patsouris, Marie Robert, Jérôme Chetritt, Delphine Loussouarn, Mario Campone, François Bocquet, Jean-Sébastien Frenel
Published in Therapeutic Advances in Medical Oncology (2025-09-01)Get full text
Article -
5
Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study by Pernelle Lavaud, Esma Saada-Bouzid, Renaud Sabatier, Olivia Le Saux, Thibault de la Motte Rouge, Anthony Gonçalves, Elodie Coquan, Jean-Sébastien Frenel, Marta Jiménez, Alice Hervieu, Laurent Mathiot, François Legrand, Claire Cropet, Edith Borcoman, Emmanuelle Charafe
Published in Journal for ImmunoTherapy of Cancer (2025-01-01)Get full text
Article
